CollabRx, Cynvenio Biosystems deal

CollabRx will provide clinical interpretation for Cynvenio's ClearID and LiquidBiopsy genomic testing services. Cynvenio will have access to multiple CollabRx products, including the Genetic Variant Annotation (GVA) Service, which provides information on the clinical impact of specific genetic profiles and associated therapeutic strategies. Clinicians and researchers ordering genomic tests from Cynvenio will have the option to receive results along with GVA-based reporting. The partners could not be reached for details. ...